{"id":8325,"date":"2017-10-02T09:32:12","date_gmt":"2017-10-02T13:32:12","guid":{"rendered":"https:\/\/medicarereport.org\/?p=8325"},"modified":"2017-10-02T09:32:12","modified_gmt":"2017-10-02T13:32:12","slug":"absent-federal-action-states-take-the-lead-on-curbing-drug-costs","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=8325","title":{"rendered":"Absent Federal Action, States Take The Lead On Curbing Drug Costs"},"content":{"rendered":"

(By Shefali Luthra for Kaiser Health News)<\/p>\n

Lawmakers in Maryland are daring to legislate where their federal counterparts have not: As of Oct. 1, the state will be able to say \u201cno\u201d to some pharmaceutical price spikes.<\/p>\n

A new law, which focuses on generic and off-patent drugs, empowers the state\u2019s attorney general to step in if a drug\u2019s price climbs 50 percent or more in a single year. The company must justify the hike. If the attorney general still finds the increase unwarranted, he or she can file suit in state court. Manufacturers face a fine of up to $10,000 for price gouging. Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"khn-logo1\"<\/a><\/p>\n

Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"
(By Shefali Luthra for Kaiser Health News) Lawmakers in Maryland are daring to legislate where their federal counterparts have not:<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,15],"tags":[],"class_list":["post-8325","post","type-post","status-publish","format-standard","hentry","category-legal-actionscourt-decisions","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8325"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8325\/revisions"}],"predecessor-version":[{"id":8326,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/8325\/revisions\/8326"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}